UCL Innovative Clinical Trials Unit
@innovative-ctu.bsky.social
We carry out innovative #ClinicalTrials and develop new #Methodology that has global impact, improving health worldwide. #MedSky #StatsSky
📢 Attending #ICTMC2026? Don't miss the keynote from Matt Sydes (mattsydes.bsky.social), Honorary Prof. of Clinical Trials & Methodology. 🗣️ "Bringing new treatments to patients: improving clinical trials with healthcare systems data" 🗓️ 16 Sept, 11:30–12:30, Hall 1 🔗 buff.ly/hYjovbd #TDfT #HDRUK
ICTMC 2026, ICC BIrmingham - ICTMC 2026 - ICC Birmingham
inconference.eventsair.com
📢 Heading to Birmingham for #ICTMC2026? Our #ClinicalTrials methodology researchers will be presenting talks, posters and workshops throughout the conference. 🔗 View the full schedule and find out where to meet the team: www.innovative-ctu.ucl.ac.uk/news/news-st...
As we mark #WorldRadiotherapyAwarenessDay, new findings from the ARCHERY study highlight the potential of AI to expand access to high-quality radiotherapy planning in low- and middle-income countries. 🔗Read more about the results: www.innovative-ctu.ucl.ac.uk/news/news-st...
AI tool for radiotherapy can support the global effort to eliminate cervical cancer | UCL Innovative Clinical Trials Unit
innovative-ctu.ucl.ac.uk
September is #GynaecologicalCancerAwarenessMonth, and we're highlighting the ICON8B trial. The study found that women with advanced #OvarianCancer lived longer when chemotherapy was given weekly alongside bevacizumab, compared with the standard treatment every 3 weeks. 🔗Read more: buff.ly/QyYtc9S
Weekly chemotherapy with bevacizumab improves ovarian cancer survival compared to having it once every three weeks | UCL Innovative Clinical Trials Unit
20 Oct 2025
innovative-ctu.ucl.ac.uk
📢 We're hiring! We are looking for a Science Communications Officer (maternity cover). A varied role creating content that showcases the impact of national & international trials in cancer, Parkinson's disease, paediatric HIV, multiple sclerosis & more. 📅 Apply by 10 Sept 2026 🔗 buff.ly/sdYteSn
UCL – University College London
UCL is consistently ranked as one of the top ten universities in the world (QS World University Rankings 2010-2022) and is No.2 in the UK for research power (Research Excellence Framework 2021).
ucl.ac.uk
Working in clinical trials and want to make better use of routinely collected healthcare data? Learn how to compare datasets and assess their suitability for specific research questions at our upcoming DUCks workshop. 📅 22 Oct 2026, 10-1 (UK time) 🔗 More information: bit.ly/3RHiUQf
What is getting in the way of efficient safety reporting in UK clinical trials? Our latest study shares insights from Clinical Trials Unit staff and includes recommendations for improving safety reporting practices. 🔗 journals.plos.org/plosone/arti...
Walking the tightrope of justifiable decision‑making: An exploratory qualitative study identifying barriers and solutions to efficient safety reporting
Background Safety reporting is integral to clinical trial conduct, aiming to protect the rights and safety of trial participants and future patients. Over time, reporting safety events has become incr...
journals.plos.org
🚨 Exciting results from the LATA trial at #AIDS2026! LATA showed that having injections every 8 weeks was better at keeping HIV under control than taking daily tablets for young people living with HIV. 🔗 Read more: www.innovative-ctu.ucl.ac.uk/news/news-st... aidsconference.bsky.social
📢 Interested in health economics in clinical trials? Don't miss the upcoming webinar from the InCTU Capacity Strengthening Hub on "How to be a Good Trial Health Economist." 📅 30 July | 10:00 AM BST Link to register 👇
The Global Health Network@tghn-news.bsky.social · 2mo agoUpcoming Webinar: How to be a good trial health economist Date and time: 30 July 2026 | 10:00 - 11:30 BST Register: zoom.us/webinar/regi...
🆕 New publication alert! Results from the PediCAP trial show that children recovering from severe pneumonia can safely switch from injectable to oral antibiotics earlier, allowing them to come home from hospital sooner. @thelancet.com 🔗 Read more: www.innovative-ctu.ucl.ac.uk/news/news-st...
Children with severe pneumonia could leave hospital sooner with oral antibiotics | UCL Innovative Clinical Trials Unit
innovative-ctu.ucl.ac.uk
🚨 New findings from the NeoVT-AMR trial! A low-cost antiseptic treatment could help protect newborn babies from life-threatening infections. The study was led by the School of Health & Medical Sciences @citystgeorges.bsky.social with support from colleagues at our Unit. 🔗 More: buff.ly/YWi4OnR
Simple antiseptic approach could help prevent deadly infections in newborn babies | City St George's, University of London
A low-cost antiseptic treatment routinely used in healthcare settings could help reduce the risk of life-threatening infections in newborn babies, according to new research led by scientists.
buff.ly
Are you attending #AIDS2026? Don't miss the latest findings from our #HIV trials! Check out the list of talks & posters from the Innovative Clinical Trials Unit researchers and our partners: www.innovative-ctu.ucl.ac.uk/news/news-st... @iasociety.bsky.social
A major milestone for GARDP's #NeoSep1 trial 🎉 The first baby has now been enrolled in Vietnam, continuing the expansion of this landmark neonatal sepsis trial from Africa into Asia.
Join our #GESISworkshop with @matteoq21.bsky.social & Tra My Pham (@innovative-ctu.bsky.social) to learn how to create, analyze, and report simulations in R/Stata. Discover when methods shine or fail, uncover their hidden biases, and compare alternatives. Registration ➡️ t1p.de/simulation_s...
📢 Call for Digital Outcome Measures proposals for the AD-SMART trial The trial team is looking for validated, patient-friendly digital tools for AD-SMART, a trial accelerating the search for better and safer Alzheimer’s treatments. 🔗 More info: www.innovative-ctu.ucl.ac.uk/studies/all-...
AD-SMART call | UCL Innovative Clinical Trials Unit
innovative-ctu.ucl.ac.uk
🎧 New Trial Talk podcast! The ACORD collaboration is bringing together experts across disciplines to transform clinical trials for neurodegenerative diseases. Hear from James Carpenter and Ed Jabbari about the vision & impact of this collaboration 👉 soundcloud.com/trial-talk-p...
The ACORD collaboration: Innovative Clinical Trials for Neurodegenerative Diseases
ACORD is a pioneering collaboration that brings together experts from a wide range of disciplines to accelerate the development of treatments for neurodegenerative diseases. In this episode, we explor
soundcloud.com
🚨 This is BIG! 👶JIPMER in India enrolled the first baby in Asia into the NeoSep1 trial. Since then, babies have been enrolled at the Rohtak site, with Mumbai next. 🧪 Led by GARDP and partners, NeoSep1 is one of the most ambitious clinical trials ever undertaken for neonatal sepsis.
🚨New results from the SNAP trial! Researchers have identified the optimal antibiotics for staph blood infection, a serious global health issue. A thread 🧵👇
🚨 New publication alert! Results from the SMAART-CHARISMA study show that artesunate (the standard treatment for severe malaria in children) remains effective, even in regions where drug resistance is rising in Africa. 🔗 Read more: www.imperial.ac.uk/news/article...
Standard malaria treatment still the best, even against resistant strains
Artesunate – the standard treatment for severe malaria in children – is still effective, even in regions of Africa where drug-resistant m...
imperial.ac.uk
📈 News from the RAMPART trial! Results presented at #ASCO26 show that using the immunotherapy drug durvalumab alone does not lower the risk of kidney cancer coming back after surgery compared with active monitoring. 🔗 Read more: www.innovative-ctu.ucl.ac.uk/news/news-st...
Using two immunotherapy drugs together benefits people with kidney cancer | UCL Innovative Clinical Trials Unit
innovative-ctu.ucl.ac.uk
We are excited to announce the launch of REFINE-MS! A new clinical trial for people living with relapsing-remitting MS, exploring whether treatment can be taken less often while still keeping disease activity under control. 🔗 Find out more: www.innovative-ctu.ucl.ac.uk/news/news-st...
A new trial for people living with relapsing-remitting multiple sclerosis launches in the UK | UCL Innovative Clinical Trials Unit
innovative-ctu.ucl.ac.uk
Heading to #ASCO26? Don’t miss James Larkin presenting new RAMPART results on whether 1 or 2 immunotherapy drugs can reduce kidney cancer recurrence vs active monitoring. 📆 30 May, 8:36–8:48 AM CDT 📍Clinical Science Symposium 🔗More about RAMPART: www.innovative-ctu.ucl.ac.uk/studies/all-...
RAMPART | UCL Innovative Clinical Trials Unit
innovative-ctu.ucl.ac.uk
Today is #InternationalClinicalTrialsDay 🌍 Patients and the public are at the heart of our research. Our #PPI group helps shape our trials, making them better, more relevant, and more inclusive. Today we’re asking our patient reps: What are you #ProudestOf in your work as part of the PPI group?
📈 New results from ARCHERY at #ESTRO26 The ARCHERY AI radiotherapy planning tool is effective in delivering timely and high-quality radiotherapy for the treatment of cervical cancer, contributing to the global effort to eliminate cervical cancer worldwide. 🔗 Read more:
AI tool for radiotherapy can support the global effort to eliminate cervical cancer | UCL Innovative Clinical Trials Unit
18 May 2026
buff.ly
Heading to #ESTRO26? Don’t miss Ajay Aggarwal presenting the first results from ARCHERY: a global trial evaluating AI-based radiotherapy treatment. 📅 18 May 2026 ⏰ 14:10 (CEST) 📍 A1 Plenary ”Highlights: Latest trials.” 🔗More about ARCHERY: archery.mrcctu.ucl.ac.uk
Home | ARCHERY
archery.mrcctu.ucl.ac.uk
It’s Wednesday, and we’re back with another #ProudestOf moment from the Unit! This week, we’re spotlighting Andy Sum, a brilliant member of the Data Management Systems team at the Unit. Andy shared what he’s #ProudestOf in his work at the Unit 👇
Midweek already? Let’s celebrate another #ProudestOf moment from our brilliant team at the Unit! This week, we’re spotlighting Alex Green, one of our dedicated Clinical Trial Managers working on paediatric HIV. Alex shared what she’s #ProudestOf in her work at the Unit 👇
🆕 New publication! A new analysis from the STAMPEDE trial shows that a routine blood test can provide valuable insight into survival in advanced prostate cancer. thelancetoncol.bsky.social 🔗 Read more: www.innovative-ctu.ucl.ac.uk/news/news-st...
A routine blood test offers new insight into survival in advanced prostate cancer | UCL Innovative Clinical Trials Unit
innovative-ctu.ucl.ac.uk
It’s Wednesday, which means we’re back with another #ProudestOf moment from the Unit! This week, we’re delighted to celebrate Angela Meade, who stepped into her new role as Director of the Innovative Clinical Trials Unit in April. Angela has shared what she’s #ProudestOf in her work at the Unit 👇
